| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 15/04/2019 | 22:32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 12/04/2019 | 19:01 | PR Newswire (US) | Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory a... | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 10/04/2019 | 22:35 | GlobeNewswire Inc. | Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019 | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 10/04/2019 | 22:19 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/04/2019 | 22:07 | GlobeNewswire Inc. | Vital Therapies, Inc. Announces Stockholder Approval of Business Combination with Immunic AG | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 02/04/2019 | 22:20 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 27/03/2019 | 21:08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 27/03/2019 | 11:00 | GlobeNewswire Inc. | Vital Therapies Reminds Stockholders to Vote For the Proposed Business Combination With Immunic AG | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 25/03/2019 | 10:00 | GlobeNewswire Inc. | Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Vital Therapies Stockholders Vote “FOR” the Prop... | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/03/2019 | 23:17 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/03/2019 | 22:10 | GlobeNewswire Inc. | Vital Therapies Announces 2018 Financial Results | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 19/02/2019 | 23:05 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 15/02/2019 | 12:33 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 14/02/2019 | 15:04 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 05/02/2019 | 00:01 | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 01/02/2019 | 21:39 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 07/01/2019 | 10:00 | GlobeNewswire Inc. | Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 08/11/2018 | 00:20 | GlobeNewswire Inc. | Vital Therapies Announces Third Quarter 2018 Financial Results | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 11/10/2018 | 15:27 | GlobeNewswire Inc. | Vital Therapies Provides Strategic Update | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 29/09/2018 | 16:00 | GlobeNewswire Inc. | Vital Therapies to Present at the 19th International Liver Support Meeting | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 26/09/2018 | 01:30 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 18/09/2018 | 12:09 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 12/09/2018 | 11:00 | GlobeNewswire Inc. | Vital Therapies Announces That Topline Results of VTL-308 Fail to Achieve Primary and Secondary Endpoints of Improvement in S... | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 07/08/2018 | 22:01 | GlobeNewswire Inc. | Vital Therapies Announces Second Quarter 2018 Financial Results | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 31/07/2018 | 22:01 | GlobeNewswire Inc. | Vital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With Webcast | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 25/06/2018 | 14:00 | GlobeNewswire Inc. | Vital Therapies Joins the Russell 3000 Index® | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 12/06/2018 | 22:30 | GlobeNewswire Inc. | Vital Therapies Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 08/06/2018 | 13:56 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3/a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 07/06/2018 | 14:00 | GlobeNewswire Inc. | Vital Therapies to Present at the Jefferies 2018 Global Healthcare Conference | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 25/05/2018 | 22:35 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |